Ligament Sprain
Of the 2 unique stories with a clear outcome, 2 reported it helped (100%).
These are public YouTube testimonials, not clinical evidence. People who tried BPC-157 and got no result rarely post videos — read this as a sample of the positive end of the distribution.
“within 24 hours of my sprain I was back to walking 100% as if nothing had happened”
“my pain and stiffness in the knee significantly dropped”
Related research
Tendon, Ligament, and Muscle Injury, Osteotendinous, Myotendinous, and Muscle-to-Bone Junction Therapy Perspectives with Growth Factors and Stable Gastric Pentadecapeptide BPC 157-A Review.
This review concludes that BPC 157, a stable gastric pentadecapeptide, shows promise in treating complex musculoskeletal and junctional injuries, with efficacy in tendon, ligament, and muscle healing. BPC 157 appears to have a full cytoprotection range and can be administered systemically or locally without a carrier.
Pentadecapeptide BPC 157 (PL 14736) improves ligament healing in the rat.
The peptide BPC-157 improved healing of medial collateral ligament injuries in rats when given intraperitoneally, locally, or per-orally. The treatment resulted in consistent functional, biomechanical, macroscopic, and histological healing improvements.
Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review.
This systematic review suggests that BPC-157 shows promise for promoting recovery from musculoskeletal injuries, with preclinical studies showing improved functional, structural, and biomechanical outcomes in muscle, tendon, ligament, and bony injuries. However, the review highlights the need for further clinical safety data and notes that adverse effects are possible due to unregulated manufacturing or contamination.
Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing.
This review concludes that BPC-157 has shown consistently positive and prompt healing effects for various soft tissue injuries in animal models, but its efficacy in humans is yet to be confirmed. The peptide has potential as a therapy for conservatively treating or aiding recovery in hypovascular and hypocellular soft tissues.